These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 23126599

  • 1. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
    Gunnlaugsdottir B, Maggadottir SM, Skaftadottir I, Ludviksson BR.
    Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
    [Abstract] [Full Text] [Related]

  • 2. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S, Tanaka J, Sugita J, Kosugi M, Shiratori S, Wakasa K, Shono Y, Shigematsu A, Kondo T, Kobayashi T, Asaka M, Imamura M.
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U.
    Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W.
    Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
    Tosiek MJ, Gruber AD, Bader SR, Mauel S, Hoymann HG, Prettin S, Tschernig T, Buer J, Gereke M, Bruder D.
    J Immunol; 2011 Jun 01; 186(11):6106-18. PubMed ID: 21518973
    [Abstract] [Full Text] [Related]

  • 12. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G, Pozo-Balado MM, Genebat M, García Pergañeda A, Leal M, Pacheco YM.
    J Infect Dis; 2012 May 15; 205(10):1501-9. PubMed ID: 22457273
    [Abstract] [Full Text] [Related]

  • 13. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X, Jie Y, Ren D, Zeng H, Zhang Y, He Y, Pan Z.
    Hum Immunol; 2012 Nov 15; 73(11):1061-7. PubMed ID: 22939904
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S, Ono S, Tsujimoto H, Kinoshita M, Takahata R, Miyazaki H, Saitoh D, Hase K.
    Surgery; 2012 Feb 15; 151(2):313-22. PubMed ID: 21982068
    [Abstract] [Full Text] [Related]

  • 17. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y, Amarnath S, Chen W.
    Transplantation; 2006 Oct 15; 82(7):953-64. PubMed ID: 17038912
    [Abstract] [Full Text] [Related]

  • 18. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A.
    Circulation; 2012 Sep 04; 126(10):1256-66. PubMed ID: 22851544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
    Sugimoto A, Suzuki M, Otani T, Okochi A, Takeuchi M, Yamasaki F, Nakamura S, Kibata M.
    Exp Hematol; 2009 Dec 04; 37(12):1454-63. PubMed ID: 19819295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.